FDA Extends Comment Period on Reclassification Rule

Devices & Diagnostics Letter
The FDA is giving devicemakers more time to comment on a proposed rule that would reclassify some devices as Class II and amend the regulations to establish special controls for others.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $10.00